Australia markets close in 1 hour 13 minutes

Senseonics Holdings, Inc. (SENS)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
3.5800+0.0200 (+0.56%)
At close: 4:00PM EDT
3.5100 -0.07 (-1.96%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close3.5600
Open3.5500
Bid3.5000 x 3200
Ask3.5300 x 4000
Day's range3.5300 - 3.6900
52-week range0.3500 - 5.5600
Volume5,871,701
Avg. volume10,352,444
Market cap1.594B
Beta (5Y monthly)0.64
PE ratio (TTM)N/A
EPS (TTM)-1.7280
Earnings date08 Nov 2021 - 12 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est3.46
  • Business Wire

    Senseonics Announces Equity Grants To Employees Under Inducement Plan

    GERMANTOWN, Md., October 04, 2021--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced that it had made equity grants to new employees under its 2019 Inducement Plan (the "Plan") in accordance with NYSE American Company Guide Section 711(a).

  • Zacks

    Implied Volatility Surging for Senseonics (SENS) Stock Options

    Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.

  • Business Wire

    Senseonics Announces a Collaboration with the University Hospitals Accountable Care Organization (UHACO) in Cleveland, Ohio

    GERMANTOWN, Md., September 13, 2021--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, and Ascensia Diabetes Care, the makers of the CONTOUR® family of diabetes blood glucose monitoring devices and commercialization partner for Senseonics, have announced that the University Hospitals Accountable Care Organiz